Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
系统性改造TROP2靶向CAR T细胞疗法可克服实体瘤的耐药通路
期刊:Cancer Immunology Research
影响因子:8.1
doi:10.1158/2326-6066.CIR-25-0527
Elliott J Brea,Simon Baldacci,Neil Savage,Francesco Facchinetti,Conor Hinchey,Sachiv Chakravarti,Alexis Mottram,Kenneth Ngo,Ha Vo,Brittaney A Leeper,Bishma Tuladhar,Suthakar Ganapathy,Elena V Ivanova,Aisha Saldanha,Marie-Anais Locquet,Abdulmajeed Salamah,Malcolm Holterhus,Evelyn B Mesler,Martina De Vizio,Carla Stornante,Marco Campisi,Navin R Mahadevan,Tran C Thai,Timothy J Haggerty,Zehua Li,Cui Nie,Changjing Deng,Xiaoxiao Wang,Louis L Liu,Thanh U Barbie,Prafulla C Gokhale,Cloud P Paweletz,Anusuya Ramasubramanian,Pasi A Jänne,David A Barbie,Eric L Smith